Reporter: Natalie Grover

'FDA Seeks More Data On Sarepta Muscle Disorder Drug, Shares Slump

Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had asked for additional data on its lead drug, delaying its marketing application by about six months.
By Natalie Grover
Most Read
  1. Sixteen Thousand Pounds Of Ground Beef Recalled For E. Coli
  2. PLANTERS Nuts Recalled Due to Listeria Risk
  3. French's Crispy Fried Onions Under Recall Over Potential Staph Contamination
  4. Apple Juice Recall Underway Due To High Levels Of Arsenic
  5. Walnuts Are Under Recall for E. Coli
News
Real Time Analytics